Which of the following is a goal of Phase 3 clinical trials?

In Phase 3 clinical trials, the primary objective is to compare the new drug with commonly used treatments, providing robust evidence of its efficacy and safety. These trials typically involve a large number of participants and are designed to ascertain how well the new treatment performs against existing therapies. This comparison helps determine whether the new drug should be approved for widespread use.

Overall, Phase 3 trials are critical in the drug development process as they establish the real-world applicability of the new treatment, informing healthcare professionals and regulatory bodies about its potential benefits and risks relative to current options. This data is essential for regulatory approval as it ensures that any new drug offers clear advantages, safety, and effectiveness compared to the standards of care already in place.